Know Cancer

or
forgot password
  • cancer clinical trials in stanford, CA

  • Molecular Genetic and Pathological Studies of Anal Tumors
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Rectal Cancer, Colon Cancer, Colonic Neoplasms, Anal Cancer
    Phase II Trial - Breast Cancer Chemoprevention by Lovastatin
    Stanford University Cancer Center
    Stanford, California 94305
    Breast Cancer
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Stanford Cancer Center
    Stanford, California 94305-5824
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer (Excluding Squamous Cell)
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lung Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Fludarabine-based Conditioning for Severe Aplastic Anemia
    Stanford Hospital and Clinics
    Stanford, California 94305
    Anemia, Aplastic
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Carcinomas (Including Squamous Cell and Adenocarcinoma), Neoplasms
    Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Hodgkin's Lymphoma
    Quality of Life Following Radical Prostatectomy
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Prostatic Neoplasms, Prostate Cancer
    Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Liver Cancer
    PET/CT and Whole-Body MRI for Detection of Skeletal and Soft Tissue Metastases
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Cancer
    Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphedema, Breast Cancer
    Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Hodgkin Disease, Lymphoma, Hodgkin Disease, Lymphoma: Hodgkin
    Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Non-Hodgkin, Hodgkin's Disease
    Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Neuroendocrine Tumors
    Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
    Stanford Hospital and Clinics
    Stanford, California 94305
    Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic Syndromes
    Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
    Stanford University
    Stanford, California 94305
    Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
    Stanford University Hospital
    Stanford, California 94303
    Mycoses, Candidiasis, Invasive, Candidemia
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
    Stanford University Medical Center Stanford Cancer Center (3)
    Stanford, California 94304
    Cushing's Disease
    Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
    Stanford University Medical Center Stanford Cancer Center (3)
    Stanford, California 94304
    Carcinoid Tumor, Acromegaly
    Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Hairy Cell Leukemia, HCL
    Trial of Dasatinib in Advanced Sarcomas
    Stanford University
    Stanford, California 94305
    Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors, Chondrosarcoma, Sarcoma, Ewing's, Sarcoma, Alveolar Soft Part, Chordoma, Epithelioid Sarcoma, Giant Cell Tumor of Bone, Hemangiopericytoma, Gastrointestinal Stromal Tumor (GIST)
    Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome
    Stanford Cancer Center
    Stanford, California 94305-5824
    Lymphoma
    Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Non-Hodgkin
    Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Prostatic Neoplasms
    Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Head and Neck Cancer, Carcinoma, Squamous Cell, Head and Neck Cancers
    Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Neoplasms
    Study of Bexxar Combined With External Beam Radiation Therapy for Patients With Relapsed, Bulky Non-Hodgkin's Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Non-Hodgkin
    Phase I/II of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoma, Mantle-Cell
    Sleep, Circadian Hormonal Dysregulation, and Breast Cancer Survival
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Stanford University
    Stanford, California 94305
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Borderline Ovarian Surface Epithelial-stromal Tumor, Ovarian Serous Cystadenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Stanford Cancer Center
    Stanford, California 94305-5824
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR
    Stanford University
    Stanford, California 94305
    Non-small Cell Lung Cancer
    Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lung Cancer
    Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer, Stomach Neoplasms, Salivary Gland Neoplasms, Thyroid Cancer
    Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Head and Neck Cancer, Lung Cancer, Lip Cancer, Lip Neoplasms, Head and Neck Cancers
    Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Myeloid, Leukemia, Acute Myeloid Leukemia (AML)
    Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Carcinoma, Giant Cell, Carcinoma, Non-Small-Cell Lung, Lung Cancer
    Molecular Analysis of Breast Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer, Breast Cancer Non-invasive Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL
    Stanford Cancer Center
    Stanford, California 94305-5824
    NSCLC
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
    Stanford Hospitals and Clinics
    Stanford, California 94305
    Acute Myeloid Leukemia
    A Study of XL184 (Cabozantinib) With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Carcinoma, Non-Small-Cell Lung
    Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
    Stanford University Medical Center Stanford Cancer Center (3)
    Stanford, California 94304
    Acromegaly
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    Stanford Hospital and Clinics
    Stanford, California 94305
    Hepatic Veno-Occlusive Disease
    Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
    Stanford University Hospital
    Stanford, California 94303
    Aspergillosis, Invasive Fungal Infections
    Improving Outcomes Assessment in Chronic GVHD
    Stanford University
    Stanford, California 94305
    Chronic Graft Versus Host Disease
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Stanford University Medical Center
    Stanford, California 94305-5408
    Venous Thrombosis
    CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
    Stanford University
    Stanford, California 94305
    Non-small Cell Lung Cancer
    Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
    Stanford University
    Stanford, California 94305
    Bladder Cancer
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    International Pediatric Adrenocortical Tumor Registry
    Stanford University
    Stanford, California 94305
    Adrenocortical Tumor
    Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Relapsing Chronic Myelogenous Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia